Unit of Reproductive Endocrinology, 1st Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki, Greece.
Unit of Reproductive Endocrinology, 1st Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki, Greece.
Metabolism. 2020 Jun;107:154193. doi: 10.1016/j.metabol.2020.154193. Epub 2020 Feb 29.
The dramatic increase in the prevalence of obesity coincides with a decline in reproductive health indices in both sexes. Energy excess mediates changes to the regulatory mechanisms of the reproductive system. Obese individuals exhibit increased estrogen concentrations, due to the overexpression of aromatase in the adipose tissue; via a negative feedback loop, men present with symptoms of hypogonadotropic hypogonadism. These hormonal changes, along with increased oxidative stress, lipotoxicity and disturbances in the concentrations of adipokines, directly affect the gonads, peripheral reproductive organs and the embryo. Clinical evidence is somewhat contradicting, with only some studies advocating worse semen parameters, increased incidence of erectile dysfunction, increased doses of ovulation induction medications, and worse live birth rates in assisted reproductive technology (ART) cycles in obese individuals compared with those of normal weight. Similar conclusions are drawn about patients with insulin resistance syndromes, namely polycystic ovary syndrome (PCOS). As far as treatment options are concerned, lifestyle changes, medical therapy and bariatric surgery may improve the reproductive outcome, although the evidence remains inconclusive. In this review, we summarize the evidence on the association of obesity and reproductive health on both the molecular and the clinical level, and the effect of weight-loss interventions on reproductive potential.
肥胖症的患病率急剧上升,与此同时,男女的生殖健康指数都出现了下降。能量过剩会影响生殖系统的调节机制。肥胖个体的雌激素浓度增加,这是由于脂肪组织中芳香酶的过度表达;通过负反馈循环,男性表现出促性腺激素低下性性腺功能减退的症状。这些激素变化,加上氧化应激增加、脂毒性和脂肪细胞因子浓度紊乱,直接影响性腺、外周生殖器官和胚胎。临床证据有些相互矛盾,只有一些研究表明肥胖个体的精液参数更差、勃起功能障碍发生率增加、排卵诱导药物剂量增加,以及辅助生殖技术 (ART) 周期中的活产率更差,而与体重正常的个体相比则相反。对于患有胰岛素抵抗综合征的患者(即多囊卵巢综合征),也得出了类似的结论。就治疗选择而言,生活方式的改变、药物治疗和减重手术可能会改善生殖结局,但证据仍不明确。在这篇综述中,我们总结了肥胖症与生殖健康在分子和临床水平上的关联的证据,以及减肥干预对生殖潜能的影响。